[go: up one dir, main page]

EE9900118A - H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel - Google Patents

H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel

Info

Publication number
EE9900118A
EE9900118A EEP199900118A EE9900118A EE9900118A EE 9900118 A EE9900118 A EE 9900118A EE P199900118 A EEP199900118 A EE P199900118A EE 9900118 A EE9900118 A EE 9900118A EE 9900118 A EE9900118 A EE 9900118A
Authority
EE
Estonia
Prior art keywords
treatment
nasal polyps
atpase inhibitors
atpase
inhibitors
Prior art date
Application number
EEP199900118A
Other languages
English (en)
Other versions
EE04043B1 (et
Inventor
Lennart Lindberg Per
Pinas-Masso Joan
Serra-Carreras Jordi
Trofast Jan
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900118A publication Critical patent/EE9900118A/et
Publication of EE04043B1 publication Critical patent/EE04043B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
EEP199900118A 1996-10-11 1997-10-01 H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks EE04043B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment
PCT/SE1997/001651 WO1998016228A1 (en) 1996-10-11 1997-10-01 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (2)

Publication Number Publication Date
EE9900118A true EE9900118A (et) 1999-10-15
EE04043B1 EE04043B1 (et) 2003-06-16

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900118A EE04043B1 (et) 1996-10-11 1997-10-01 H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks

Country Status (33)

Country Link
EP (1) EP0946175B1 (et)
JP (1) JP4100713B2 (et)
KR (1) KR100510812B1 (et)
CN (1) CN1146416C (et)
AR (1) AR008886A1 (et)
AT (1) ATE230597T1 (et)
AU (1) AU738310B2 (et)
BR (1) BR9711896A (et)
CA (1) CA2268305C (et)
CZ (1) CZ298799B6 (et)
DE (1) DE69718347T2 (et)
DK (1) DK0946175T3 (et)
EE (1) EE04043B1 (et)
ES (1) ES2188995T3 (et)
HU (1) HUP0000036A3 (et)
ID (1) ID23692A (et)
IL (1) IL129324A0 (et)
IS (1) IS1930B (et)
MY (1) MY117918A (et)
NO (1) NO321007B1 (et)
NZ (1) NZ334786A (et)
PL (1) PL190902B1 (et)
PT (1) PT946175E (et)
RS (1) RS49599B (et)
RU (1) RU2197966C2 (et)
SA (1) SA97180641B1 (et)
SE (1) SE9603725D0 (et)
SK (1) SK284252B6 (et)
TR (1) TR199900770T2 (et)
TW (1) TW568784B (et)
UA (1) UA59374C2 (et)
WO (1) WO1998016228A1 (et)
ZA (1) ZA978842B (et)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
HRP20010119B1 (hr) 1998-08-18 2008-05-31 The Regents Of The University Of California Sprječavanje stvaranja sluzi u dišnim putevima primjenom antagonista egf-r
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
PL206121B1 (pl) * 1999-03-03 2010-07-30 Optinose Asoptinose As Nosowe urządzenie do dostarczania substancji do nosowej części dróg oddechowych pacjenta
US20050020637A1 (en) * 2001-11-19 2005-01-27 Wolfgang-Alexander Simon Agents for the treatment of airway disorders
AU2003218726A1 (en) * 2002-03-14 2003-09-22 Altana Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders
RS95304A (sr) * 2002-05-07 2006-12-15 Altana Pharma Ag. Nova kombinacija za tretman oboljenja disajnih puteva
JP2005526848A (ja) * 2002-05-07 2005-09-08 アルタナ ファルマ アクチエンゲゼルシャフト 気道疾患を治療するための組み合わせ
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
RS51707B (sr) 2002-12-12 2011-10-31 Nycomed Gmbh. Kombinacija leka sastavljena od r, r - formoterola i ciklezonida
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DK1670482T4 (da) 2003-09-16 2022-08-22 Covis Pharma B V Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
RU2252025C1 (ru) * 2003-11-28 2005-05-20 Дальневосточный государственный медицинский университет Способ лечения избыточной грануляционной ткани гортани и трахеи
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
RU2197966C2 (ru) 2003-02-10
IS5021A (is) 1999-04-08
JP2001508034A (ja) 2001-06-19
CA2268305A1 (en) 1998-04-23
ZA978842B (en) 1998-04-14
IL129324A0 (en) 2000-02-17
HK1022848A1 (en) 2000-08-25
TW568784B (en) 2004-01-01
SK284252B6 (sk) 2004-12-01
EE04043B1 (et) 2003-06-16
RS49599B (sr) 2007-06-04
HU0000036D0 (et) 2002-05-29
DE69718347D1 (de) 2003-02-13
UA59374C2 (uk) 2003-09-15
CZ122999A3 (cs) 1999-09-15
CA2268305C (en) 2006-11-28
IS1930B (is) 2004-05-18
CZ298799B6 (cs) 2008-02-06
PL332692A1 (en) 1999-09-27
KR20000049046A (ko) 2000-07-25
MY117918A (en) 2004-08-30
DE69718347T2 (de) 2003-08-28
KR100510812B1 (ko) 2005-08-31
PL190902B1 (pl) 2006-02-28
SK38499A3 (en) 2000-03-13
NO991619L (no) 1999-04-06
HUP0000036A3 (en) 2003-02-28
JP4100713B2 (ja) 2008-06-11
EP0946175A1 (en) 1999-10-06
CN1232397A (zh) 1999-10-20
NO991619D0 (no) 1999-04-06
WO1998016228A1 (en) 1998-04-23
CN1146416C (zh) 2004-04-21
EP0946175B1 (en) 2003-01-08
PT946175E (pt) 2003-04-30
HUP0000036A2 (hu) 2002-05-29
NO321007B1 (no) 2006-02-27
TR199900770T2 (xx) 1999-06-21
NZ334786A (en) 2000-12-22
AR008886A1 (es) 2000-02-23
SA97180641B1 (ar) 2005-12-18
YU16399A (sh) 2000-03-21
ID23692A (id) 2000-05-11
DK0946175T3 (da) 2003-03-17
ES2188995T3 (es) 2003-07-01
ATE230597T1 (de) 2003-01-15
SE9603725D0 (sv) 1996-10-11
AU738310B2 (en) 2001-09-13
AU4640997A (en) 1998-05-11
BR9711896A (pt) 1999-08-24

Similar Documents

Publication Publication Date Title
EE9900118A (et) H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel
FI20000863A0 (fi) Uusi hoitomenetelmä
DE69719108D1 (de) Plasmabehandlungsgerät
DE60026704D1 (de) (S,S)-Reboxetine zur Behandlung chronischer Schmerzen
DK1304992T3 (da) Topisk gel-fremföringssystem til behandling af hudlidelser
DE69929047D1 (de) Haarbehandlungsmittel
EE200100370A (et) Teraapias kasutatavad spirofuropüridiinide uued aralküülamiinid
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
IS6560A (is) Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni
DE60041641D1 (de) Plasma behandlungsapparat
IS5756A (is) Notkun hreinljósvirks (+) -norkisapríðs við meðhöndlun á öndunarstöðvun, lotugræðgi og öðrum meinum
NO20005179D0 (no) Medikament behandling
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69732024D1 (de) Haarbehandlungsmittel
NO20013337D0 (no) Ny behandling
DE60023003D1 (de) Haarbehandlungsmittel
NO20013596L (no) Slambehandling
DE60037935D1 (de) Kontinuierliches behandlungssystem
IT1284920B1 (it) Trattamento del diamante
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
DK1135128T3 (da) Nye behandlingsfremgangsmåder
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081001